We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$219M
AUM Growth
+$6.83M
Cap. Flow
-$6.43M
Cap. Flow %
-2.93%
Top 10 Hldgs %
11.02%
Holding
358
New
139
Increased
60
Reduced
65
Closed
94

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.93M
2
L icon
Loews
L
+$2.68M
3
DVA icon
DaVita
DVA
+$2.26M
4
BF.B icon
Brown-Forman Class B
BF.B
+$2.1M
5
UHS icon
Universal Health Services
UHS
+$1.98M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$5.2M
2
TRIP icon
TripAdvisor
TRIP
+$4.25M
3
IPGP icon
IPG Photonics
IPGP
+$4.19M
4
HAIN icon
Hain Celestial
HAIN
+$4.02M
5
DLTR icon
Dollar Tree
DLTR
+$4M

Sector Composition

Rank Sector Weight
1 Healthcare 15.2%
2 Consumer Discretionary 13.52%
3 Technology 12.57%
4 Financials 12.4%
5 Industrials 12.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RL icon
201
Ralph Lauren
RL
$22.5B
$459K 0.21%
+3,487
New +$516K
GDOT icon
202
Green Dot
GDOT
$758M
$452K 0.21%
28,392
+19,802
+231% +$339K
HCI icon
203
HCI Group
HCI
$2.29B
$445K 0.2%
9,705
+6,027
+164% +$279K
GNCMA
204
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$440K 0.2%
+27,893
New +$409K
WHG icon
205
Westwood Holdings Group
WHG
$187M
$439K 0.2%
7,273
+4,520
+164% +$275K
CRM icon
206
Salesforce
CRM
$149B
$417K 0.19%
+6,246
New +$387K
PGEN icon
207
Precigen
PGEN
$1.97B
$416K 0.19%
9,583
+6,187
+182% +$222K
VRA icon
208
Vera Bradley
VRA
$104M
$416K 0.19%
+25,614
New +$472K
BRCM
209
DELISTED
BROADCOM CORP CL-A
BRCM
$395K 0.18%
+9,120
New +$398K
MCHP icon
210
Microchip Technology
MCHP
$41.1B
$394K 0.18%
16,114
-96,212
-86% -$2.32M
KYTH
211
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$393K 0.18%
7,836
+3,254
+71% +$137K
EBS icon
212
Emergent Biosolutions
EBS
$377M
$392K 0.18%
13,637
+6,575
+93% +$189K
NRC icon
213
NRC Health Common Stock
NRC
$503M
$391K 0.18%
+27,129
New +$383K
MANT
214
DELISTED
Mantech International Corp
MANT
$391K 0.18%
+11,522
New +$378K
TSRO
215
DELISTED
TESARO, Inc.
TSRO
$391K 0.18%
6,820
+1,093
+19% +$51.5K
SAGE
216
DELISTED
Sage Therapeutics
SAGE
$390K 0.18%
+7,768
New +$334K
IPGP icon
217
IPG Photonics
IPGP
$3.57B
$387K 0.18%
4,180
-48,499
-92% -$4.19M
UTHR icon
218
United Therapeutics
UTHR
$26.1B
$386K 0.18%
2,239
-34,105
-94% -$5.2M
ADVM
219
DELISTED
Adverum Biotechnologies
ADVM
$374K 0.17%
+923
New +$390K
OLED icon
220
Universal Display
OLED
$3.85B
$373K 0.17%
7,976
-41,366
-84% -$1.47M
ARIA
221
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$372K 0.17%
+45,105
New +$333K
SGMO
222
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$367K 0.17%
+23,413
New +$362K
MGNX icon
223
MacroGenics
MGNX
$245M
$360K 0.16%
+11,484
New +$389K
KPTI icon
224
Karyopharm Therapeutics
KPTI
$161M
$357K 0.16%
777
+522
+205% +$225K
PBYI icon
225
Puma Biotechnology
PBYI
$406M
$352K 0.16%
+1,492
New +$319K
7 8
9
10 11

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
AAG
Avalon Advisory Group Wexford, Pennsylvania $248M AUM 11.89% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return

Capital Impact Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, Capital Impact Advisors held 358 positions worth $219M, up 3.2% from $212M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Capital Impact Advisors's Q1 2015 filing shows 139 new, 60 increased, 65 reduced and 94 closed positions. Its largest new stake was Aflac: 95,898 shares worth $3.07M. The largest sale was United Therapeutics, an estimated $5.2M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Capital Impact Advisors's largest Q1 2015 buy was Aflac: 95,898 shares worth $3.07M.
  • Capital Impact Advisors added most to Titan Machinery in Q1 2015, an estimated $1.12M increase.
  • Capital Impact Advisors's biggest Q1 2015 reduction was United Therapeutics, cutting an estimated $5.2M.
  • Capital Impact Advisors fully exited TripAdvisor in Q1 2015, selling an estimated $4.25M.
  • Capital Impact Advisors's ten largest holdings make up 11% of its $219M portfolio in Q1 2015.
  • Capital Impact Advisors opened 139 new positions and closed 94 in Q1 2015.
  • Capital Impact Advisors's portfolio value rose 3.2% quarter-over-quarter to $219M.

Based on Capital Impact Advisors's 13F filing for Q1 2015, filed 29 May 2015.